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Abstract
The binding of cis-diamminedichloroplatinum (DDCP) and cis-diaquodiammine platinum (DADP) to
rabbit skeletal muscle G-actin and the consequent conformation changes were studied as the function of the
Pt/actin molar ratio (R) and time by intrinsic and NPM labeled fluorescence, CD spectra as well as gel-
filtration chromatography. The results indicated that the unhydrolyzed DDCP can react with G-actin in
presence ofCI ion. The reaction differs from that of its hydrolysis product DADP in a higher specificity and
a lower capacity. Both of them induced exposure of the tryptophane residues and labeled Cys374 and the
increase in z-helix content depending on R, but the conformation changes caused by DADP are more
significant than DDCP at the same R. These are related to the binding ofDADP to groups other than thiols.
The rate constants of conformation change suggested that DADP quenched the intrinsic fluorescence more
rapid. The temporal change in fluorescence of NPM labeled actin has a biphasic feature: in the first 16
minutes, the fluorescence was quenched, then it recovered slowly, indicating a multi-step reaction including
high affinity platinum binding--, labeled Cys374 moving to hydrophilic environment-* low affinity platinum
binding--, Cys374-related conformation compacting in sequence.
Introduction
The interpretation of the anticancer mechanism of cis-diamminedichloroplatinum (DDCP) and the
guidelines for designing new antineoplastic platinum complexes have been mostly based on the interaction
with DNA. However, the activity and toxicity are both the manifestation of all the events occurring in the
course of drug-cell interaction, in which the involvement of non-DNA targets is also important. Evidences
accumulated in recent years support that the microfilament system is susceptible to be attacked by platinum
complexestl-51. The microfilaments are in a dynamic state of interconversion between monomer (G-actin)
and polymer (F-actin). We found DDCP and cis-diaquodiammine platinum (DADP) to affect the self-
association of G-actin, but in somewhat different ways[6"7]. In order to clarify the mechanism of this action
and the difference between DDCP and DADP, the investigation on DDPC (its hydrolysis was inhibited by
0.1 mol/L NaCI) and DADP binding to G-actin has been performed in the present work using spectroscopic
and chromatographic techniques.
Materials and Reagents
Chemicals
cis-Diamminedichloroplatinum obtained from Qilu Pharmaceutical Factory. Na2ATP, Sodium azide and
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N-(1-pyrenyl) maleimide (NPM) were from Sigma Chemical Co.. All other reagents were of analytical grade
and used without further purification, and all solutions were prepared with deionized water. Buffer A (pH 8.0)
was composed of 2mol/L Tris, 0.2mmol/L CaClz, 0.005% NAN3. In the study of DDCP-actin, NaC1 was
added (0.1mol/L) in order to inhibit hydrolysis, while in the case of DADP-actin, 0.1 mol/L NaCIO4 was
added instead to keep the ionic strength constant.
Preparation ofDADP Solution
cis-Diamminedichloroplatinum and silver nitrate (molar ratio 1:1.98) were stirred in the dark at room
temperature for 12h. The reaction mixture was chilled and filtered. No Ag+ was found in the filtrate by
checking with 0. mol/L KC1.
Purification of G-actin
G-actin was extracted from rabbit skeletal muscle as described previouslytSJ. G-actin concentration was
determined according to the absorbance at 290nm with the absorption coefficient A
mg/, =0.63tsj and
29O
checked with Lowry’s methodt9J. The level of impurities in the actin is less than 0.5% as determined by SDS
-polyacrylamide gel electrophoresistl.
Instruments and Methods
Instruments
All fluorescence measurements were conducted with a Shimadzu RF-540 spectrophotofluorimeter with
slits for both excitation and emission set at 5nm. The CD spectra were recorded on a Jasco-500c polarizing
spectrophotometer. The assays of platinum were performed with AA-40P Varian atomic absorption
spectrophotometer (AAS).
Gel-filtration Chromatographic Study on the Platinum Binding to G-actin
G-actin was allowed to react with a 22-fold molar excess of DDCP or DADP at 20C for 16h and 28h.
The samples were then chromatographed on Sephadex G-25 columns equilibrated and eluted with buffer A.
The platinum content in each eluted fraction was determined by AAS. The protein content of selected
fractions was determined by Lowry’s method.
Study on the Intrinsic Fluorescence Change of G-actin Induced by the Platinum Complexes
The test solutions were prepared by incubating aliquots of G-actin solution (0.4tmol/L) with various
amounts ofDDCP or DADP for 12h at 4C The concentrations of Pt (II) complexes were varied in the range
0-40 lamol/L. The intrinsic fluorescence of samples was measured with ex=286nm and ,em=340nm at room
temperature.
The Reaction of Platinated G-actin with NPM
The Pt(II)-actin solutions were prepared by incubating G-actin (0.4tmol/L) with various volumes of
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DDCP (2.0mmol/L) or DADP (2.0mmol/L) stock solution. After standing at 4C for 12h, 25tl lmmol/L
NPM solution was added to each of the solutions, and left overnight at 4 C. The fluorescence measurements
were conducted with ,ex=342nm and Z,em=375nm.
The Reaction ofNPM Labeled G-actin with DDCP or DADP
G-actin was labeled previously with NPM by Kawasaki’s methodtl] with a molar ratio 1.0 ofNPM to
actin. After standing 24h at 4C and dialyzing against buffer A to remove the free NPM, the solution was
diluted to 0.4 tmol/L. The NPM labeled G-actin solutions were treated with increasing volumes ofDDCP or
DADP solutions. After standing overnight at 4 C, the fluorescence was measured with an excitation
wavelength of342nm and an emission wavelength of 375nm.
CD Measurements
CD spectra were recorded at room temperature. G-actin concentration was 0.4 tmol/L and DDCP or
DADP concentrations varied in the range of 0-321amol/L. The spectra were scanned from 240nm to 190nm
and repeated four times at sensitivity 2cm-.
The Conformation Change of G-actin Induced by Platinum Binding
Fluorescence measurements were performed in a temperature-controlled cuvette chamber. The cell
holder was thermostated at 25 +0.2C. The spectra of DDCP-actin and DADP-actin were recorded at the
same time. The quenching effect ofDDCP or DADP on the intrinsic fluorescence of G-actin was observed at
G-actin concentration of 8.35 lamol/L, and the molar ratio ofDDCP or DADP to G-actin is 21.8. The change
ofNPM labeling fluorescence was studied at the G-actin concentration of 0.971amol/L and a molar ratio of
DDCP or DADP to G-actin of 21.0.
Results
The Reaction ofDDCP or DADP with G-actin
By means of gel-filtration chromatography with Sephadex G-25, the free platinum complexes were
separated from the protein, including the platinum bound protein. When G-actin was incubated with DDCP
and DADP separately, 5.6mol DDCP and 3.3mol DADP were bound to each mol of G-actin. When the time
of incubation was extended to 28h, the average binding numbers in both case were almost unchanged.
Titration curves based on intrinsic fluorescence of G-actin showed that the fluorescence was quenched
by DDCP or DADP. An increase of DDCP concentration affected the fluorescence only slightly but, for
DADP, the effect was more significant (Figure 1).
Scatchard plots based on the fluorescence titration data are given in Figure 2 and 3. We define
Y=[PtL]/Cactin, here [PtL] refers to the concentration of the bound Pt and Cactin is the concentration of G-
actin. A nonlinear regression approach was used for the best fitting and the results indicated that the binding
sites might be categorized into two groups both ofDDCP and DADP: for DDCP, high affinity binding sites
with an average binding constant KI=3.0106 L/mol, and a number of binding sites n1=23; low affinity
binding sites with K_=5.1xl05 L/mol, n2=38; for DADP, high affinity binding sites with Kl=l.7xl06 L/mol,
n=40; low affinity binding sites with K2=4.6 105 L/mol, n=60.
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FIGURE 1. The changes of intrinsic
fluorescence of G-actin with increasing
platinurn/actin molar ratio. C,,=0.4tmol/L,
buffer A. DDCP(-); DADP(+).
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FIGURE 2. Scatchard plot of DDCP binding
to G-actin. The experimental conditions see
the text. C,=0.41amol/L, buffer A.
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FIGURE 6. c-helix content as a function of
platinum/actin molar ratio. C,a,=0.4tmol/L,
buffer A. DDCP (-); DADP(+).
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FIGURE 3. Scatchard plot of DADP
binding to G-actin. The experimental
conditions were described in the text.
C,,,=0.4tmol/L, buffer A.
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The Reaction ofDDCP-actin or DADP-actin with NPM
Since NPM binds to Cys374 specifically, it can be deduced that NPM reacts with the Cys374
unoccupied by platinum complexes when G-actin was treated previously with DDCP or DADP. The
fluorescence intensity decreased very slightly with increasing DDCP concentration, but the fluorescence
intensity decreased dramatically for DADP in the range of Pt/actin less than 20 (Figure 4A and 5A).
The Reaction ofNPM Labeled G-actin with DDCP or DADP.
When labeled G-actin was titrated by DDCP or DADP, the profiles of the change in fluorescence
intensity (Figure 4B and 5B) resembles those given in Figure 4A and 5A respectively.
Cirular Dichroism Measurements
The a-helix content was estimated on the basis ofthe mean residue ellipticity 02os, as shown on Figure 6.
The (x-helix content were increased from 12% to 19% (DDCP), from 12% to 18% (DADP) linearly with the
increasing R to 3 5. After then, no changes were observed.
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FIGURE 4. The changes of NPM labeled
fluorescence as a function of DDCP/actin
molar ratio. C,=0.4p.mol/L, buffer A. Curve
A(+): G-actin was incubated with DDCP at
first, then DDCP-actin was labeled by NPM.
Curve B (.): G-actin was previously labeled
with NPM and free NPM was removed
completely, then titrated with DDCP.
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FIGURE 5. The changes of NPM labeled
fluorescence as a function of DADP/actin
molar ratio. C,,=0.4tmol/L, buffer A. Curve
A(+): G-actin was incubated with DADP at
first, then DADP-actin was labeled by NPM.
Curve B (*): G-actin was previously labeled
with NPM and free NPM was removed
completely, then titrated with DADP.
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The Change of Conformation of G-actin Induced by DDCP or DADP
DDCP or DADP binding to G-actin was reflected in the temporal change of intrinsic fluorescence as
given in Figure 7 and NPM labeling fluorescence (Figure 8). In the presence of DDCP or DADP, the
fluorescence intensity ofNPM label was quenched sharply in the first 16 min, then it recovered slowly, but a
monotonous decreasing of the intrinsic fluorescence was observed in both DDCP and DADP. The pseudo-
first order rate constants for the change of fluorescence are summarized in Table 1.
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FIGURE 7. DDCP(.) and DADP(+) binding
to G-actin and conformation changes
monitored at 25"C by intrinsic fluorescence as
a function of time. C,=n=8.35tmol/L, CDp=
CDp=1.82x 10"mol/L, buffer A.
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FIGURE 8. DDCP(*) and DADP(+) binding
to G-actin and conformation changes
monitored at 25"C by NPM labeling
fluorescence as a function of time. C,a,, =0.97
tmol/L, Ctc=Ctp=20.4tmol/L, buffer A.
Table 1. The rate contants of conformation change
by intrinsic fluorescence by fluorescence of NPM labeled G-actin
rate constant (min-1)
DDCP
DADP
k k (t<l6min) k2 (t>16min)
1.47x 10.3 1.25x 10.2 7.31 x 10-4
4.06x 10.3 1.18x 10-2 4.59x 10-4
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Discussion
There are two possible pathways for DDCP-protein reactionst2, i.e. direct ligand exchange with S-
donors of the protein and, indirectly, via the hydrolysis product, DADP. It can be expected that, in the
presence of a sufficiently high concentration of CI" ion, inhibiting the hydrolysis of DDCP, the reactive
species will be the unhydrolyzed DDCP and the solely possible reaction will be the direct displacement of
ligand CI by a S-donor. In contrast, in media of lower CI concentration, the reactant is mainly DADP since
the complex hydrolyzes (tl/2~9h at room temperature)t3. DADP reacts 10 times faster than DDPCt12, but the
difference between DDCP and DADP is not only a kinetic one: the binding capacity and specificity can also
play an important role, because DADP tends to react with most of the nucleophilic groups in the protein,
including N- and O-donors. It is thus deduced that the binding capacity ofDADP is higher than DDCP, and
the specificity of binding is less than DDCP. The gel-filtration chromatographic studies gave evidence for
the difference in binding capacity. The number of binding sites of DDCP was shown to be only 60% of
DADP, as determined on the basis of fluorescence titration.
It is expectable that these differences will cause differences in conformation change. Both DDCP and
DADP quenched the intrinsic fluorescence continuously with the increasing concentration (see figure 1),
indicating that the tryptophane residues moved to a more hydrophilic environment by binding to high- and
low-affinity sites, but since DDCP binds S-donor mainly at lower concentration, the quenching effect
became much less at R>20.
The difference between DDCP and DADP became more evident as reflected in NPM-labeled
fluorescence, which is an indicator of the microenvironment of Cys-374 in C-terminal. As seen from Figure
4B and 5B, DDCP reduced the NPM fluorescence ofNPM-labeled actin monotonously, while the quenching
effect ofDADP was characterized by a biphasic mode depending on concentration, i. e. a significant drop in
fluorescence at lower R and then a very slight reduction over R=20. This might be interpreted by considering
that the binding to high-affinity sites caused strong effect to push the C-terminal into the aqueous medium,
but the further binding to low-affinity sites caused less effect.
If G-actin was treated previously with DDCP or DADP before labeling with NPM, then the NPM
molecules can only react with the thiol groups unoccupied by platinum (Figure 4A and 5A). Comparing the
curves of A and B for DDCP or DADP, it can be found that the NPM labeled fluorescence changed in a
similar way for either of them, no matter G-actin was incubated with platinum complexes before labeled by
NPM or G-actin was labeled by NPM before reacted with platinum complexes. It is reasonable that the
reaction of DDCP with thiols is more difficult than that of DADP, since it can be seen that a much lower
concentration ofDADP is required to reach the equilibrium state than DDCP.
Although the secondary structure of G-actin was affected by both DDCP and DADP, the effect ofDDCP
was much less pronounced than that ofDADP. For lower R values (R<20), the c-helix increased as the result
ofplatinum binding to high-affinity sites. Above this limit, a further increase in t% was observed for DDCP,
though with a smaller concentration dependence, but DADP caused no further change. The increase in c-
helix content might be related to intermolecular and intramolecular cross-linking. This inference was
supported by the result of polyacrylamide gel electrophoresistTJ.
According to Figure 8, as the results of DDCP and DADP actions, the kinetic of the Cys374-related
conformation changes in a similar way. At the initial stage, a rapid reaction was believed to be the DDCP and
DADP binding to sulfur donors of both methionine and cysteine residues; in a second stage, a further slow
binding of the platinum complexes to other sites brought about a further conformation change and the
molecules became more compact. For DDPC, the pseudo-first order rate constant is 1.6-fold higher than for
DADP in this stage (Table 1). The exposure oftryptophane residues proceeded accompanying the C-terminal
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conformation change. The rate constants revealed that the tryptophane residues were moved to a more
opened environment much faster by DADP than DDCP.
In summary, the results reported here indicate that DDCP can react with G-actin directly, but the
reaction is different from that of DADP-actin. Since DADP is able to bind to a number of additional sites,
especially those other than sulfur donors, the binding ofDADP was characterized by a higher capacity and a
lower specificity compared to DDCP. As a result, DADP is more potential to affect conformation of G-actin
than DDCP, which is the source of the difference between DDCP and DADP in affecting the self-association
of G-actin. Hence, it is very important for a platinum complex to hydrolyze at a suitable rate. It is expected
that a very slow aquation rate of a platinum complex leads to a less effective binding to DNA and a low-
anticancer activity. In contrary, a platinum complex which hydrolyzes too rapidly will react significantly
with proteins and cause high toxicity.
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